Perri, P., Curcio, F., De Luca, M., Piro, P., Trombino, S. and Cassano, R., 2025. Evaluation of Chitosan-Based Axiostat as Hemostatic Dressing for Endovascular Procedures in Patients with Leriche Syndrome…
Read MoreEfficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers
Publication Details
Minici, R., Serra, R., Maglia, C., Guzzardi, G., Spinetta, M., Fontana, F., Venturini, M. and Laganà, D., 2023. Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers. Journal of Personalized Medicine, 13(5), p.812.
Key Findings
- Effectiveness and safety of Axiostat® for femoral arterial access closure in endovascular procedures.
- Comparison of Axiostat® outcomes in endovascular procedure using various sheath sizes.
Core Results
Rate of Successful Hemostasis – 91.7%
Clinical success (no bleeding-related vascular access site complication) – 94.2%
Mean time-to-achieving hemostasis – 8.9 ± 3.9 minutes.
Time-to-ambulation – 462 ± 199 minutes. (around 7 and half hours)
No event of thrombosis, neuropathy, AV fistula formation.
No event of re bleeding complication and infection at the bleeding wound site. Key Insights & Discussion
- Axiostat® is effective and safe for achieving hemostasis at the femoral arterial access site during endovascular procedures regardless of sheath sizes.
- Axiostat® assist in rapid hemostasis and early ambulation in all patient groups.
More Publications
